Rewiring tumor cells to undergo drug-induced apoptosis is a promising way to overcome chemoresistance. Therefore, identifying causative factors for chemoresistance is of high importance. Unbiased global proteome profiling of sensitive, early, and late cisplatin-resistant oral squamous cell carcinoma (OSCC) lines identified CMTM6 as a top-ranked upregulated protein. Analyses of OSCC patient tumor samples demonstrated significantly higher CMTM6 expression in chemotherapy (CT) nonresponders as compared with CT responders. In addition, a significant association between higher CMTM6 expression and poorer relapse-free survival in esophageal squamous cell carcinoma, head and neck squamous cell carcinoma, and lung squamous cell carcinoma was observed from Kaplan-Meier plot analysis. Stable knockdown (KD) of CMTM6 restored cisplatin-mediated cell death in chemoresistant OSCC lines. Upon CMTM6 overexpression in CMTM6-KD lines, the cisplatin-resistant phenotype was rescued. The patient-derived cell xenograft model of chemoresistant OSCC displaying CMTM6 depletion restored the cisplatin-induced cell death and tumor burden substantially. The transcriptome analysis of CMTM6-KD and control chemoresistant cells depicted enrichment of the Wnt signaling pathway. We demonstrated that CMTM6 interaction with membrane-bound Enolase-1 stabilized its expression, leading to activation of Wnt signaling mediated by AKT–glycogen synthase kinase-3β. CMTM6 has been identified as a stabilizer of programmed cell death ligand 1. Therefore, as CMTM6 facilitates tumor cells for immune evasion and mediates cisplatin resistance, it could be a promising therapeutic target for treating therapy-resistant OSCC.
Pallavi Mohapatra, Omprakash Shriwas, Sibasish Mohanty, Arup Ghosh, Shuchi Smita, Sandeep Rai Kaushik, Rakesh Arya, Rachna Rath, Saroj Kumar Das Majumdar, Dillip Kumar Muduly, Sunil K. Raghav, Ranjan K. Nanda, Rupesh Dash
Title and authors | Publication | Year |
---|---|---|
Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors
Duan SL, Jiang Y, Li GQ, Fu W, Song Z, Li LN, Li J |
PeerJ | 2024 |
Wnt/β-catenin-driven EMT regulation in human cancers.
Xue W, Yang L, Chen C, Ashrafizadeh M, Tian Y, Sun R |
Cellular and molecular life sciences : CMLS | 2024 |
Tolypothrix Dichloromethane Ethylacetate fraction (TDEF) inhibits cisplatin resistance H357 cell through PI3K/AKT/beta-catenin pathway
Heisnam R, Thoithoisana Devi S, Mohanty S, Mukherjee PK, Rayala VP, Radhakrishnanand P, Dash R, Sharma N |
American journal of cancer research | 2024 |
WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway
Zhang X, Sun K, Gan R, Yan Y, Zhang C, Zheng D, Lu Y |
BMC Cancer | 2024 |
Onco-Ontogeny of Squamous Cell Cancer of the First Pharyngeal Arch Derivatives
Sat-Muñoz D, Balderas-Peña LM, Gómez-Sánchez E, Martínez-Herrera BE, Trujillo-Hernández B, Quiroga-Morales LA, Salazar-Páramo M, Dávalos-Rodríguez IP, Nuño-Guzmán CM, Velázquez-Flores MC, Ochoa-Plascencia MR, Muciño-Hernández MI, Isiordia-Espinoza MA, Mireles-Ramírez MA, Hernández-Salazar E |
International Journal of Molecular Sciences | 2024 |
Lanthanide conjugate Pr-MPO elicits anti-cancer activity by targeting lysosomal machinery and inducing zinc-dependent cataplerosis
Bellot GL, Liu D, Fivaz M, Yadav SK, Kaur C, Pervaiz S |
Cell Communication and Signaling : CCS | 2024 |
HNCDrugResDb: a platform for deciphering drug resistance in head and neck cancers.
Palollathil A, Nandakumar R, Ahmed M, Velikkakath AKG, Nisar M, Nisar M, Devasahayam Arokia Balaya R, Parate SS, Hanehalli V, Mahin A, Mathew RT, Shetty R, Codi JAK, Revikumar A, Vijayakumar M, Prasad TSK, Raju R |
Scientific reports | 2024 |
Identification of ENO-1 positive extracellular vesicles as a circulating biomarker for monitoring of Ewing sarcoma.
Uotani K, Fujiwara T, Ueda K, Yoshida A, Iwata S, Morita T, Kiyono M, Kunisada T, Takeda K, Hasei J, Yoshioka Y, Ochiya T, Ozaki T |
Cancer science | 2024 |
Role of ENO1 and its targeted therapy in tumors.
Li Y, Liu L, Li B |
Journal of translational medicine | 2024 |
CMTM6 status predicts survival in head and neck squamous cell carcinoma and correlates with PD-L1 expression
Becker AS, Wieder N, Zonnur S, Zimpfer A, Krause M, Schneider B, Strüder DF, Burmeister AS, Erbersdobler A, Junghanss C, Maletzki C |
Discover Oncology | 2024 |
Epigenetic Activation of the CMTM6‐IGF2BP1‐EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
Zhu Y, Huang Y, Shi Y, Huang C, Zhao G, Liu Z, Ma M, Ye J, Xu X, Liu Q, Huang X, Wang J, Xu Q, Yin X |
Advanced Science | 2024 |